Duract (bromfenac) was on the market less than a year

July 1998

Duract (bromfenac) was on the market less than a year.

This NSAID worked well for acute pain, but got pulled becauseof reports of severe hepatic failure in patients who used Duract formore than 10 days or had pre-existing hepatic disease.

In fact, its labeling had a black-box warning not to take itfor more than 10 days because of the risk of hepatic toxicity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote